273 related articles for article (PubMed ID: 22029673)
1. Altered angiogenesis in the tumor microenvironment.
Hida K; Kawamoto T; Ohga N; Akiyama K; Hida Y; Shindoh M
Pathol Int; 2011 Nov; 61(11):630-7. PubMed ID: 22029673
[TBL] [Abstract][Full Text] [Related]
2. Tumour endothelial cells acquire drug resistance in a tumour microenvironment.
Hida K; Akiyama K; Ohga N; Maishi N; Hida Y
J Biochem; 2013 Mar; 153(3):243-9. PubMed ID: 23293323
[TBL] [Abstract][Full Text] [Related]
3. Characterization of molecular and functional alterations of tumor endothelial cells to design anti-angiogenic strategies.
Bussolati B; Deregibus MC; Camussi G
Curr Vasc Pharmacol; 2010 Mar; 8(2):220-32. PubMed ID: 19485921
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis--characteristics of tumor endothelial cells.
Hida K; Maishi N; Torii C; Hida Y
Int J Clin Oncol; 2016 Apr; 21(2):206-212. PubMed ID: 26879652
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Tumor Endothelial Cells in Cancer Progression.
Hida K; Maishi N; Annan DA; Hida Y
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695087
[TBL] [Abstract][Full Text] [Related]
6. Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies.
Hida K; Hida Y; Shindoh M
Cancer Sci; 2008 Mar; 99(3):459-66. PubMed ID: 18167133
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated endothelial cells with cytogenetic abnormalities.
Hida K; Hida Y; Amin DN; Flint AF; Panigrahy D; Morton CC; Klagsbrun M
Cancer Res; 2004 Nov; 64(22):8249-55. PubMed ID: 15548691
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of tumor endothelial cells.
Hida K; Ohga N; Akiyama K; Maishi N; Hida Y
Cancer Sci; 2013 Nov; 104(11):1391-5. PubMed ID: 23930621
[TBL] [Abstract][Full Text] [Related]
9. Isolation of endothelial cells from human tumors.
Naschberger E; Schellerer VS; Rau TT; Croner RS; Stürzl M
Methods Mol Biol; 2011; 731():209-18. PubMed ID: 21516410
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation.
Collet G; Skrzypek K; Grillon C; Matejuk A; El Hafni-Rahbi B; Lamerant-Fayel N; Kieda C
Vascul Pharmacol; 2012; 56(5-6):252-61. PubMed ID: 22446152
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.
Matejuk A; Collet G; Nadim M; Grillon C; Kieda C
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):285-99. PubMed ID: 23575964
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis: from molecular mechanisms to translational implications.
Li B; Xiu R
Clin Hemorheol Microcirc; 2013; 54(4):345-55. PubMed ID: 23241508
[TBL] [Abstract][Full Text] [Related]
13. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
Nicoli S; Ribatti D; Cotelli F; Presta M
Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
[TBL] [Abstract][Full Text] [Related]
14. Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies.
Dutour A; Rigaud M
Anticancer Res; 2005; 25(6B):3799-807. PubMed ID: 16309166
[TBL] [Abstract][Full Text] [Related]
15. Molecular heterogeneity of tumor endothelium.
Aird WC
Cell Tissue Res; 2009 Jan; 335(1):271-81. PubMed ID: 18726119
[TBL] [Abstract][Full Text] [Related]
16. Suprabasin as a novel tumor endothelial cell marker.
Alam MT; Nagao-Kitamoto H; Ohga N; Akiyama K; Maishi N; Kawamoto T; Shinohara N; Taketomi A; Shindoh M; Hida Y; Hida K
Cancer Sci; 2014 Dec; 105(12):1533-40. PubMed ID: 25283635
[TBL] [Abstract][Full Text] [Related]
17. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic cancer therapy.
Cao Y
Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898
[TBL] [Abstract][Full Text] [Related]
19. Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies.
Maes H; Olmeda D; Soengas MS; Agostinis P
FEBS J; 2016 Jan; 283(1):25-38. PubMed ID: 26443003
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells.
Otsubo T; Hida Y; Ohga N; Sato H; Kai T; Matsuki Y; Takasu H; Akiyama K; Maishi N; Kawamoto T; Shinohara N; Nonomura K; Hida K
Cancer Sci; 2014 May; 105(5):560-7. PubMed ID: 24602018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
